Detalhe da pesquisa
1.
Dual κ-agonist/µ-antagonist opioid receptor modulation reduces levodopa-induced dyskinesia and corrects dysregulated striatal changes in the nonhuman primate model of Parkinson disease.
Ann Neurol
; 77(6): 930-41, 2015 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-25820831
2.
Transformation of dolutegravir into an ultra-long-acting parenteral prodrug formulation.
Nat Commun
; 13(1): 3226, 2022 06 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35680875